Navigation Links
Athens Regional Medical Center Upgrades to Omnicell G4 Platform for Supply and Medication Management
Date:11/3/2011

MOUNTAIN VIEW, Calif., Nov. 3, 2011 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced that Athens Regional Medical Center has upgraded its Omnicell supply and medication management solutions with the new fourth generation Omnicell® G4 platform. After nearly a decade as an Omnicell pharmacy and supply automation customer, the medical center's upgrade demonstrates its commitment to improving patient care and clinician efficiency.

Committed to advancing medication and supply automation management, Athens Regional began its Omnicell G4 platform upgrade process in mid-2011 with the G4 OptiFlex™ MS for surgical supply management and OptiFlex CL for interventional radiology needs. The medical center's next G4 upgrades are scheduled to go live in January 2012 with enhanced medication management technology, including the OmniRx® G4 Automated Medication Dispensing Cabinets (ADCs) to efficiently manage, store, and dispense medications throughout the medical center. At the same time, Athens Regional intends go live with Omnicell's Controlled Substance Management System (CSM) to provide perpetual inventory management and closed-loop tracking for controlled substances.

"Omnicell has bee
'/>"/>

SOURCE Omnicell, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. ESHREs workshop on freezing of human sperm, eggs and embryos in Athens
2. Regional partnership to develop algal biofuels gets backing of San Diego leaders
3. University of Houston Site of Regional Center of Excellence
4. More pain means real gain in complex regional pain syndrome treatment
5. Announcing IOF Regionals 1st Asia-Pacific osteoporosis meeting
6. Singapore program to provide clinical insight; showcase for regional research
7. Register now for the IOF Regionals -- 1st Asia-Pacific Osteoporosis Meeting
8. New York City Regional Extension Center Selects Greenway
9. Cornells regional sun grant energy conference is May 24-26
10. The great pond experiment: Regional vs. local biodiversity
11. US greenhouse gas emissions and capture, regionally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/6/2015)... JOSE, Calif. , Aug. 6, 2015 /PRNewswire/ ... leading developer of human interface solutions, today announced ... TouchPad technologies on Windows 10. Microsoft leveraged Synaptics, ... to the operating system. Through ... drivers are fully certified with Microsoft,s Precision TouchPad ...
(Date:8/5/2015)... The biosensors market is proving highly attractive ... newer sectors, and development of devices resulting in higher ... seen the entry of multiple participants each year with ... (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) Recent ... Global Biosensors Market ( http://www.frost.com/nee9 ), finds that ...
(Date:8/3/2015)... Synaptics, Inc. (Nasdaq: SYNA ), the ... members of the executive management team will present to ... Leadership Forum on Tuesday, August 11, 2015 at 1:00 ... the Sonnenalp Resort in Vail, CO. ... information. An audio webcast of the event will be ...
Breaking Biology News(10 mins):Synaptics Chosen for Human Interface Co-Development on Windows 10 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
... at the University of Rochester have found that small-bodied ... anti-cancer mechanism that appears to be different from any ... The findings are published in today,s issue of ... cancer in humans because many human cancers originate from ...
... Song-Charng Kong,s Iowa State University laboratory have come a ... combustion engine in 1879. There are fuel injectors ... efficiency, cleaner burning and greater reliability. But ... and all kinds of sensors recording engine cylinder pressure, ...
... for years about why uranium contamination in groundwater continues ... at the south end of the Hanford Site. The ... persists. Now, an innovative system has been ... site and to support future cleanup decisions. The site ...
Cached Biology News:Novel anti-cancer mechanism found in long-lived rodents 2Iowa State engineer works to clean and improve engine performance 2Sophisticated monitoring array to address mystery of uranium plume 2Sophisticated monitoring array to address mystery of uranium plume 3
(Date:8/28/2015)... ... ... launch of FireflySci Inc. (FFS) in early 2015, the company continues to shake up the ... Fonz in a lab coat and Large Marge have been posted on the company’s Facebook ... FireflySci is proud to be the only cuvette manufacturer is the world that has an ...
(Date:8/27/2015)... 27, 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") ... Biohaven Pharmaceutical Holding Company Limited (Biohaven), announced today ... study of BHV-0223, a glutamate modulating agent. Biohaven ... and recently obtained clearance from the U.S. Food ... testing. Portage holds 54% equity interest in Biohaven, ...
(Date:8/27/2015)... , Aug. 27, 2015 HUYA Bioscience International ... of the Japan Society of HTLV-1, held this week ... The purpose of the Society is to promote research ... development of medical technology and research related to these ... "HUYA is proud to support this prestigious ...
(Date:8/27/2015)... PARK, N.C. , Aug. 27, 2015 /PRNewswire/ ... the decision by FedEx, UPS and The US ... certain biological specimens classified as ,select agents, by ... long history of handling these sensitive shipments. ... of global transportation regulations, trained and certified personnel ...
Breaking Biology Technology:Cuvette Manufacturer FireflySci Launches Back to School Deals with Complimentary Shipping On All Orders 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4Marken Ensures Safe Transportation Of Select Agents And Toxins 2
... BioStorage Technologies, Inc.,(BST) will serve as the biorepository ... Study, a new landmark longitudinal study of coronary ... of Indianapolis and surrounding areas as study participants ... drugs and diagnostics that allow,doctors to better manage ...
... 23 Tengion Inc., a clinical,stage biotechnology company focused ... it has appointed Mark Stejbach as Vice,President, Marketing and ... marketing, sales, finance, and managed care experience from,both Merck ... very pleased to welcome Mark to the Tengion executive ...
... Delivers Solid Financial Performance While Building for the Future, ... GENZ ) today reported strong sales and profit growth ... commercial and clinical,programs., Revenue increased 25 percent to ... quarter. The increase was driven by,growth across all areas ...
Cached Biology Technology:BioStorage Technologies Serves as Repository for Landmark Study of Coronary Artery Disease 2Tengion Appoints Mark Stejbach Vice President of Marketing & Commercial Planning 2Genzyme Reports Strong Second-Quarter Growth 2Genzyme Reports Strong Second-Quarter Growth 3Genzyme Reports Strong Second-Quarter Growth 4Genzyme Reports Strong Second-Quarter Growth 5Genzyme Reports Strong Second-Quarter Growth 6Genzyme Reports Strong Second-Quarter Growth 7Genzyme Reports Strong Second-Quarter Growth 8Genzyme Reports Strong Second-Quarter Growth 9Genzyme Reports Strong Second-Quarter Growth 10Genzyme Reports Strong Second-Quarter Growth 11Genzyme Reports Strong Second-Quarter Growth 12Genzyme Reports Strong Second-Quarter Growth 13Genzyme Reports Strong Second-Quarter Growth 14Genzyme Reports Strong Second-Quarter Growth 15Genzyme Reports Strong Second-Quarter Growth 16Genzyme Reports Strong Second-Quarter Growth 17
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selecitivty and potential CNS-Side Effect liabilities of compo...
... Endogens Screening Sets contain the ... develop five colorimetric sandwich ELISA plates ... in 100 l/well of cell culture ... and Detection Antibodies, Recombinant Standard (5 ...
... The organic acid analysis ... of six organic salts; molecular ... 294. This standard is provided ... HPX-87H column and the organic ...
... and size analyzer offering a wide dynamic range. ... in mind. It is comprised of a chemically ... The system is completely computer controlled. The modular ... such as dry or where smaller volumes are ...
Biology Products: